Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

Disni Muringampurath-John; Christopher R. Flowers; Michael Toscano; Chen Zhengjia; Jonathan L. Kaufman; Martha Arellano; Leon Bernal-Mizrachi; Leonard T. Heffner; Mary Jo Lechowicz; Morgan McLemore; Elliott Winton; David L. Jaye; Sagar Lonial; Hanna Jean Khoury

doi:10.3109/10428194.2011.619019

Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

Disni Muringampurath-John, Christopher R. Flowers, Michael Toscano, Chen Zhengjia, Jonathan L. Kaufman, Martha Arellano, Leon Bernal-Mizrachi, Leonard T. Heffner, Mary Jo Lechowicz, Morgan McLemore, Elliott Winton, David L. Jaye, Sagar Lonial, Hanna Jean Khoury

Pathology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	725-727
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	53
Issue number	4
DOIs	https://doi.org/10.3109/10428194.2011.619019
State	Published - Apr 1 2012

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2011.619019

Cite this

Muringampurath-John, D., Flowers, C. R., Toscano, M., Zhengjia, C., Kaufman, J. L., Arellano, M., Bernal-Mizrachi, L., Heffner, L. T., Lechowicz, M. J., McLemore, M., Winton, E., Jaye, D. L., Lonial, S., & Khoury, H. J. (2012). Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. Leukemia and Lymphoma, 53(4), 725-727. https://doi.org/10.3109/10428194.2011.619019

Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. / Muringampurath-John, Disni; Flowers, Christopher R.; Toscano, Michael et al.
In: Leukemia and Lymphoma, Vol. 53, No. 4, 01.04.2012, p. 725-727.

Research output: Contribution to journal › Letter › peer-review

Muringampurath-John, D, Flowers, CR, Toscano, M, Zhengjia, C, Kaufman, JL, Arellano, M, Bernal-Mizrachi, L, Heffner, LT, Lechowicz, MJ, McLemore, M, Winton, E, Jaye, DL, Lonial, S & Khoury, HJ 2012, 'Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma', Leukemia and Lymphoma, vol. 53, no. 4, pp. 725-727. https://doi.org/10.3109/10428194.2011.619019

@article{121acaf09a2f4caa927326f6711f3d24,

title = "Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma",

author = "Disni Muringampurath-John and Flowers, {Christopher R.} and Michael Toscano and Chen Zhengjia and Kaufman, {Jonathan L.} and Martha Arellano and Leon Bernal-Mizrachi and Heffner, {Leonard T.} and Lechowicz, {Mary Jo} and Morgan McLemore and Elliott Winton and Jaye, {David L.} and Sagar Lonial and Khoury, {Hanna Jean}",

year = "2012",

month = apr,

day = "1",

doi = "10.3109/10428194.2011.619019",

language = "English (US)",

volume = "53",

pages = "725--727",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

AU - Muringampurath-John, Disni

AU - Flowers, Christopher R.

AU - Toscano, Michael

AU - Zhengjia, Chen

AU - Kaufman, Jonathan L.

AU - Arellano, Martha

AU - Bernal-Mizrachi, Leon

AU - Heffner, Leonard T.

AU - Lechowicz, Mary Jo

AU - McLemore, Morgan

AU - Winton, Elliott

AU - Jaye, David L.

AU - Lonial, Sagar

AU - Khoury, Hanna Jean

PY - 2012/4/1

Y1 - 2012/4/1

UR - http://www.scopus.com/inward/record.url?scp=84859025266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859025266&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.619019

DO - 10.3109/10428194.2011.619019

M3 - Letter

C2 - 21888615

AN - SCOPUS:84859025266

SN - 1042-8194

VL - 53

SP - 725

EP - 727

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this